If marketing’s participation isn’t already incorporated into a company’s official product development process, they’re missing the boat. The post Marketing’s Untapped Opportunity in the Medical Product Lifecycle appeared first on MedCity News.
While high-acuity options must remain for those that need stronger interventions, millions more could be benefiting from access to low-acuity or minimal interventions. The post The Workforce is Suffering from Chronic Back Pain — It’s Time for a New Approach appeared first on MedCity News.
The National Institutes of Health employee said she knew things would be difficult for federal workers after Donald Trump was elected. But she never imagined it would be like this. Focused on Alzheimer’s and other dementia research, the worker is among thousands who abruptly lost their jobs in the Trump administration’s federal workforce purge. The…
HELENA, Mont. — Mark Nay’s first client had lost the van she was living in and was struggling with substance use and medical conditions that had led to multiple emergency room visits. Nay helped her apply for Medicaid and food assistance and obtain copies of her birth certificate and other identification documents needed to apply…
By MATT McCORD American manufacturing is making a comeback. Driven by tariffs, supply chain instability, and shifting economic priorities, companies are reshoring production—reinvesting in U.S. labor and operations. But there’s one major obstacle still standing in the way: the crushing cost of American healthcare. For decades, U.S. employers have overpaid for healthcare without improving outcomes….
The Improving Care and Access to Nurses (ICAN) Act would cut the red tape for advanced practice nurses to provide care, says AANA’s president
Apellis Pharmaceuticals and Astellas Pharma have the first two FDA-approved therapies for geographic atrophy, but Character Biosciences claims its approach could be best in class for treating this advanced form of dry age-related macular degeneration. The biotech’s Series B round will finance clinical tests of two programs, each addressing a different stage of the disease….
Navina closed a $55 million Series C funding round led by Goldman Sachs. The company, based in Israel and New York, uses AI to help primary care physicians thrive in value-based care models. The post Navina Snags $55M for Its Value-Based Care AI Copilot appeared first on MedCity News.
Following evidence showing that bacterial vaginosis affects both men and women, Wisp has launched a male BV partner treatment. The post Wisp Unveils Male Bacterial Vaginosis Partner Treatment appeared first on MedCity News.
Provides ten key facts about the U.S. global health response, as it was before the Trump administration began.